SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

REPLIGEN CORP
Date: Sept. 10, 2025 · CIK: 0000730272 · Accession: 0000000000-25-009806

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-14656

Date
September 10, 2025
Author
Finance
Form
UPLOAD
Company
REPLIGEN CORP

Letter

Re: Repligen Corporation Form 10-K for Fiscal Year Ended December 31, 2024 File No. 000-14656 Dear Jason K. Garland:

September 10, 2025

Jason K. Garland Chief Financial Officer Repligen Corporation 41 Seyon Street Building 1, Suite 100 Waltham, MA 02453

We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 September 10, 2025

Jason K. Garland
Chief Financial Officer
Repligen Corporation
41 Seyon Street
Building 1, Suite 100
Waltham, MA 02453

 Re: Repligen Corporation
 Form 10-K for Fiscal Year Ended December 31, 2024
 File No. 000-14656
Dear Jason K. Garland:

 We have completed our review of your filings. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>